Bristol-Myers Squibb Company
ACYL SULFONAMIDE NAV1.7 INHIBITORS

Abstract:

The present disclosure relates to compounds of formula I which inhibit NaV1.7, and include pharmaceutically acceptable salts, compositions comprising such compounds, and methods using and making such compounds and compositions. (I) ##STR00001##